Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlotta Zampieri

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Drug Targets|November 23, 2019
Plasminogen Receptors in Human Malignancies: Effects on Prognosis and Feasibility as Targets for Drug DevelopmentSteven L Gonias, Carlotta Zampieri
Biology Direct|August 7, 2021
Understanding p53 tumour suppressor networkEmanuele Panatta, Carlotta Zampieri, Gerry Melino, et al.
Biology Direct|August 5, 2021
NUAK2 and RCan2 participate in the p53 mutant pro-tumorigenic networkEleonora Mammarella, Carlotta Zampieri, Emanuele Panatta, et al.
Molecular Oncology|December 17, 2021
p53 mutations define the chromatin landscape to confer drug tolerance in pancreatic cancerCarlotta Zampieri, Emanuele Panatta, Vincenzo Corbo, et al.
The Journal of Biological Chemistry|August 4, 2025
The urokinase receptor/uPAR is a major effector of p53 gain-of-function mutations in gemcitabine-treated pancreatic ductal adenocarcinomaCarlotta Zampieri, Kourosh Kouhmareh, Parnian Sartipdolagh, et al.
JCI Insight|June 27, 2023
An LRP1-binding motif in cellular prion protein replicates cell-signaling activities of the full-length proteinElisabetta Mantuano, Carlotta Zampieri, Pardis Azmoon, et al.
Biology Direct|March 8, 2022
p53-driven lipidome influences non-cell-autonomous lysophospholipids in pancreatic cancerAlessio Butera, Micaela Roy, Carlotta Zampieri, et al.
Journal of Cellular Biochemistry|March 22, 2023
An antibody that targets cell-surface glucose-regulated protein-78 inhibits expression of inflammatory cytokines and plasminogen activator inhibitors by macrophagesCory B Gunner, Pardis Azmoon, Elisabetta Mantuano, et al.
Journal of Neuroinflammation|December 8, 2019
Fibrinolysis protease receptors promote activation of astrocytes to express pro-inflammatory cytokinesPaola Pontecorvi, Michael A Banki, Carlotta Zampieri, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 26, 2024
Selective metabolic regulations by p53 mutant variants in pancreatic cancerSabrina Caporali, Alessio Butera, Alessia Ruzza, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Drug Targets|November 23, 2019
Plasminogen Receptors in Human Malignancies: Effects on Prognosis and Feasibility as Targets for Drug DevelopmentSteven L Gonias, Carlotta Zampieri
Biology Direct|August 7, 2021
Understanding p53 tumour suppressor networkEmanuele Panatta, Carlotta Zampieri, Gerry Melino, et al.
Biology Direct|August 5, 2021
NUAK2 and RCan2 participate in the p53 mutant pro-tumorigenic networkEleonora Mammarella, Carlotta Zampieri, Emanuele Panatta, et al.
Molecular Oncology|December 17, 2021
p53 mutations define the chromatin landscape to confer drug tolerance in pancreatic cancerCarlotta Zampieri, Emanuele Panatta, Vincenzo Corbo, et al.
The Journal of Biological Chemistry|August 4, 2025
The urokinase receptor/uPAR is a major effector of p53 gain-of-function mutations in gemcitabine-treated pancreatic ductal adenocarcinomaCarlotta Zampieri, Kourosh Kouhmareh, Parnian Sartipdolagh, et al.
JCI Insight|June 27, 2023
An LRP1-binding motif in cellular prion protein replicates cell-signaling activities of the full-length proteinElisabetta Mantuano, Carlotta Zampieri, Pardis Azmoon, et al.
Biology Direct|March 8, 2022
p53-driven lipidome influences non-cell-autonomous lysophospholipids in pancreatic cancerAlessio Butera, Micaela Roy, Carlotta Zampieri, et al.
Journal of Cellular Biochemistry|March 22, 2023
An antibody that targets cell-surface glucose-regulated protein-78 inhibits expression of inflammatory cytokines and plasminogen activator inhibitors by macrophagesCory B Gunner, Pardis Azmoon, Elisabetta Mantuano, et al.
Journal of Neuroinflammation|December 8, 2019
Fibrinolysis protease receptors promote activation of astrocytes to express pro-inflammatory cytokinesPaola Pontecorvi, Michael A Banki, Carlotta Zampieri, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 26, 2024
Selective metabolic regulations by p53 mutant variants in pancreatic cancerSabrina Caporali, Alessio Butera, Alessia Ruzza, et al.
Pageof 1